This study investigates the impact of personalized AI-generated video advertisements on consumer click-through rates (CTR), aiming to understand the effectiveness of personalized content in the ...

Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

The cost of a bad hire can be devastating for a small business. This is the story of my biggest hiring disaster and the red flags I wish I'd recognized earlier.

The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily ...

Clinical trials are an essential step in medical science; they are the key. They serve to answer questions about the safety ...

Perfuse Therapeutics is conducting trials for the treatment for glaucoma and diabetic retinopathy, aiming to restore vision ...

Altimmune, Inc.'s pemvidutide shows promising results in MASH resolution and weight loss, paving the way for phase 3 trials.

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Iya Khalil, PhD, discusses Merck & Co.’s approach to artificial intelligence (AI), and success in applying the technology, ...

This is a useful study in the role of CHI3L1 in Kupffer cells, the macrophages of the liver, showing that CHI3L1 alters glucose regulation in obesity. Specifically, Chi3l1 protects glucose-dependent ...

Anaphylm's FDA approval process is a major catalyst, with a PDUFA date set for January 31, 2026. Find out why Aquestive ...